Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 225-208-0 | CAS number: 4719-04-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu./o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Ames test: negative with and without metabolic activation (BASF SE, 1997)
HPRT test: negative with and without metabolic activation (BASF SE, 2002)
Chromosomal aberration test: positive with and without metabolic activation (BASF SE, 2002)
Link to relevant study records
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- in vitro mammalian chromosome aberration test
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Lot/batch No.of test material: 1157 - Species / strain / cell type:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- with and without
- Metabolic activation system:
- Metabolic activation was achieved by addition of S-9 mix, which consisted of the S-9 fraction from the liver of male Wistar Hanlbm rats treated with Phenobarbital i.p. and ß-Naphthoflavone p.o., mixed with a series of cofactors.
- Test concentrations with justification for top dose:
- 2.5, 5.0, 10.0, 20.0, 30.0, and 40.0 µg/mL (with and without S9-mix)
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: water, nutrient medium
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: Ethylmethane sulfonate and Cyclophosphamide
- Details on test system and experimental conditions:
- DURATION
- Exposure duration: 4 hours
- Expression time (cells in growth medium): 18 hours
- Selection time (if incubation with a selection agent): 14 hours
SELECTION AGENT (mutation assays): Chromosomes
NUMBER OF CELLS EVALUATED: 1E+06
DETERMINATION OF CYTOTOXICITY:
Toxicity of the test substance is indicated by a reduction of mitotic indeces.
S9 mix Preparation:
Metabolic activation was achieved by addition of S-9 mix, which consisted of the S-9 fraction from the liver of male Wistar Hanlbm rats treated with Phenobarbital i.p. and ß-Naphthoflavone p.o., mixed with a series of cofactors (MgCl2, KCl, Glucose-6-phosphate, NADP in sodium-ortho-phosphate buffer).
Dose Selection:
The highest concentration used in the pre-test was chosen with regard to the current OECD Guideline for in vitro mammalian cytogenetic tests. 3000 µg/mL of the aqueous test substance solution (corresponds to approx . 10 mM of the active ingredient) were applied as top concentration for treatment of the cultures in the pre-test. Test substance concentrations between 23.4 and 3000 µg/mL (with and without S9-mix) were chosen for the evaluation of cytotoxicity. In the pre-test on toxicity, in the absence of S9 mix only precipitation of the test substance after 4 hrs treatment was observed at 1500 µg/mL and above.
Using reduced cell numbers as an indicator for toxicity in the pre-test, clear toxic effects were observed after 4 hrs treatment with 23.4 µg/mL and above in the absence and the presence of S9 mix. In addition, 24 hrs continuous treatment with 23.4 µg/ml and above in the absence of S9 mix induced strong toxic effects. Considering the toxicity data of the pre-test, 40 µg/mL (with and without S9 mix) were chosen as top concentrations in the main experiment. Since the test substance was considered to be clastogenic after 4 hrs treatment a second experiment was not performed.
Negative Controls:
Concurrent negative (culture medium) and solvent controls (deionised water) were performed.
Positive Controls:
- Without metabolic activation: Ethylmethane sulfonate (EMS), purity: >98%, dissolved in: nutrient medium, final conc.: 400 µg/mL = 3.2 mM
- With metabolic activation: Cyclophosphamide (CPA), purity: approx. 98%, dissolved in: nutrient medium, final conc.: 0.7 µg/mL = 2.5 µM - Evaluation criteria:
- A test substance is classified as non-clastogenic if:
- the number of induced structural chromosome aberrations in all evaluated dose groups are in the range of the historical control data of the performing laboratory (0.0 - 4.0 % aberrant cells exclusive gaps).
A test substance is classified as clastogenic if :
- the number of induced structural chromosome aberrations are not in the range of the historical control data (0.0 - 4.0 % aberrant cells exclusive gaps).
and
- either a concentration-related or a significant increase of the number of structural chromosome aberrations is observed.
However, both biological and statistical significance should be considered together . If the criteria mentioned above for the test substance are not clearly met, the classification with regard to the historical data and the biological relevance is discussed and/or a confirmatory experiment is performed.
Although the inclusion of the structural chromosome aberrations is the purpose of this study, it is important to include the polyploids and endoreduplications. The following criteria is valid:
A test substance can be classified as aneugenic if:
- the number of induced numerical aberrations are not in the range of the historical control data (0.0 % - 8.5 % polyploid cells). - Statistics:
- Statistical significance was confirmed by means of the Fisher"s exact test (Ricardson C. et al., 1989): p < 0.05.
- Key result
- Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- with and without
- Genotoxicity:
- positive
- Cytotoxicity / choice of top concentrations:
- other: 30 µg/mL without S9-mix; 40 µg/mL with S9-mix
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- other: OECD Guideline 471 (Bacterial Reverse Mutation Assay) / OECD Guideline 472 (Genetic Toxicology: Escherichia coli, Reverse Mutation Assay)
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Lot/batch No.of test material: PK 95/222
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: refrigerated - Target gene:
- his- or trp-
- Species / strain / cell type:
- other: Salmonella typhimurium TA1535, TA1537, TA98, TA100, TA102, E. coli WP2 uvrA
- Additional strain / cell type characteristics:
- not applicable
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 mix (Aroclor 1254 induced rat liver)
- Test concentrations with justification for top dose:
- 25 µg - 7500 µg/plate
- Vehicle / solvent:
- water
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Remarks:
- water
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: 2- Aminoanthracene, N-Methyl-N'-nitro-N-nitrosoguanidine, Mitomycin C, 4-Nitro-o-phenylendiamine, 9-Aminoacridine chloride monohydrate and N-Ethyl-N'-nitro-N-nitrosoguanidine.
- Details on test system and experimental conditions:
- The test was conducted according to the Ames procedure (standard plate test and preincubation test , with and without metabolic activation).
Number of plates: 3 test plates per dose or per control.
Vehicle: water
The study comprised 6 independent experiments:
1st Experiment:
- Strains: TA 1535, TA 100, TA 1537, TA 98.
- Doses: 0, 100, 500, 2500, 5000 and 7500 µg/plate.
- Test condition: Standard plate test with and without S-9 mix.
2nd Experiment:
- Strains: TA 1535, TA 100, TA 1537, TA 98.
- Doses: 0, 25, 50, 100, 200 and 400 µg/plate.
- Test condition: Standard plate test with and without S-9 mix.
3rd Experiment:
- Strains: TA 1535, TA 100, TA 1537, TA 98.
- Doses: 0, 25, 50, 100, 200 and 400 µg/plate.
- Test condition: Preincubation test with and without S-9 mix.
4th Experiment:
- Strains: TA 1535, TA 100, TA 1537, TA 98.
- Doses: 0, 25, 50, 100, 200 and 400 µg/plate.
- Test condition: Standard plate test with and without S-9 mix.
5th Experiment:
- Strains: TA 102, E. coli WP2 uvrA.
- Doses: 0, 25, 50, 100, 200 and 400 µg/plate.
- Test condition: Preincubation test with and without S-9 mix.
6th Experiment:
- Strains: TA 102.
- Doses: 0, 25, 50, 100, 200 and 400 µg/plate.
- Test condition: Standard plate test with and without S-9 mix.
Positive control substance:
- With S-9 mix: 2- Aminoanthracene for the strains TA 100, TA 98, TA 1537, TA 1535, TA 102 and E. coli WP2 uvrA.
- Without S-9 mix: N-Methyl-N' -nitro-N-nitrosoguanidine (strains TA 100 and TA 1535); Mytomycin C (strain TA 102); 4-Nitro-o-phenylendiamine (strain TA 98); 9-Aminoacridine chloride monohydrate (strain 1537) and N-Ethyl-N' -nitro-N-nitrosoguanidine (strain E. coli WP2 uvrA). - Evaluation criteria:
- The assessment for the test was based on the number of histidine or tryptophan revertant colonies per plate.
In general, a substance to be characterized as positive in the Ames test has to fulfill the following requirements:
- doubling of the spontaneous mutation rate (control)
- dose-response relationship
- reproducibility of the results. - Key result
- Species / strain:
- other: Salmonella typhimurium TA1535, TA1537, TA98, TA100, TA102, E. coli WP2 uvrA
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- other: from about 400 µg - 500 µg/plate onward.
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- mammalian cell gene mutation assay
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Lot/batch No.of test material: 1157 - Target gene:
- HPRT locus
- Species / strain / cell type:
- Chinese hamster lung fibroblasts (V79)
- Additional strain / cell type characteristics:
- not applicable
- Metabolic activation:
- with and without
- Metabolic activation system:
- Metabolic activation was achieved by addition of S-9 mix, which consisted of the S-9 fraction from the liver of male Wistar rats treated with Phenobarbital i.p. and ß-Naphthoflavone p.o., mixed with a series of cofactors.
- Test concentrations with justification for top dose:
- Experiment I:
1.6, 3.1, 6.3, 12.5, and 25 µg/mL (with and without S9-mix)
Experiment II:
3.1, 6.3, 12.5, 25 and 30 µg/mL (without S9-mix)
3.1, 6.3, 12.5, 20 and 25 µg/mL (with S9-mix) - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO, water
- Untreated negative controls:
- yes
- Remarks:
- untreated cells
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO, water
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: Ethylmethane sulfonate (without metabolic activation) and 7,12-Dimethylbenz(a)anthracene (with metabolic activation).
- Details on test system and experimental conditions:
- The essay was performed in 2 independent experiments.
DURATION
- Exposure duration: 4 hours
- Expression time (cells in growth medium): 7 days
- Selection time (if incubation with a selection agent): about 8 days
SELECTION AGENT (mutation assays): 6TG (6-Thioguanine)
NUMBER OF REPLICATIONS: 5
NUMBER OF CELLS EVALUATED: 1E+06
DETERMINATION OF CYTOTOXICITY:
Toxicity of the test substance is indicated by a reduction of the cloning efficiency.
TEST SYSTEM:
- S9 mix preparation:
Metabolic activation was achieved by addition of S-9 mix, which consisted of the S-9 fraction from the liver of male Wistar Hanlbm rats treated with
Phenobarbital i.p. and ß-Naphthoflavone p.o., mixed with a series of cofactors (MgCl2, KCl, Glucose-6-phosphate, NADP in sodium-ortho-phosphate buffer).
- Dose selection:
A pre-test was performed in order to determine the concentration range for the mutagenicity experiments. In this pre-test, the colony forming ability of approximately 500 single cells (duplicate cultures per concentration level) after treatment with the test substance was observed and compared to
the controls. Eight concentrations were chosen ranging from 23.4 to 3000 µg/mL with and without metabolic activation and a treatment duration of 4 hours. Toxic effects occurred down to the lowest concentration with and without metabolic activation. Already at 93.8 µg/mL without and at 46.9 µg/mL with metabolic activation, the cell growth was completely inhibited. Therefore, the maximal concentration of the test substance (25.0 µg/mL) in the first main experiment was based upon the toxicity of the test substance observed in the pre-experiment. The dose range of the second experiment was adjusted according to the results of the first experiment to cover the toxic range more closely.
CONTROLS:
Negative Controls:
Concurrent negative and solvent controls were performed. As negative controls: untreated cells were used (cells were cultivated without interruption) and cells, used throughout the assay without addition of test substance.
Positive Controls:
- Without metabolic activation: Ethylmethane sulfonate (EMS), purity: >98%, dissolved in: nutrient medium, final conc.: 0.15 mg/mL = 1.2 mM
- With metabolic activation: 7,12-Dimethylbenz(a)anthracene (DMBA), purity: approx. 95%, dissolved in: DMSO, final conc.: 2.7 µg/mL = 10.4 µM
METHOD OF APPLICATION: in suspension
- Evaluation criteria:
- A test substance is classified as positive if it induces a concentration-related increase of the mutant frequency.
A test substance producing neither a concentration-related increase of the mutant frequency nor a reproducible positive response at any of the test points is considered non-mutagenic in this system.
A positive response is described as follows :
A test substance is classified as mutagenic if it reproducibly induces a mutation frequency that is three times above the spontaneous mutation frequency at least at one of the concentrations in the experiment and if this increase exceeds the range of the historical negative or solvent control data of the testing laboratory.
The test substance is classified as mutagenic if there is a reproducible concentration-related increase of the mutation frequency. Such evaluation
may be considered also in the case that a threefold increase of the mutant frèquency is not observed.
However, in a case by case evaluation this decision depends on the level of the corresponding negative control data. If there is by chance a low spontaneous mutation rate in the range normally found (0.5 - 33.1 mutants per 1E+06 cells) a concentration-related increase of the mutations within this
range has to be discussed. - Key result
- Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- other: 25 µg/mL with S9 mix; 25 and 30 µg/mL without S9 mix
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- The assay was performed in 2 independent experiments with and without liver microsomal activation and a treatment period of 4 hours. Since experiment I showed no indication of a possible mutagenic potential of the test substance, a second confirmatory experiment was performed with and without metabolic activation. The ratio of S9/cofactor solution was 1:2.0 in experiment I and 1:9.0 in experiment II with metabolic activation.
In the main experiments relevant toxic effects occurred at 25.0 and 30.0 µg/mL in the absence and at 25.0 µg/mL in the presence of metabolic activation. A rather steep gradient of dose dependent toxicity was observed in the second experiment especially in the presence of metabolic activation.
No relevant and reproducible increase in mutant colony numbers 1E+06 cells was observed in the main experiments up to the maximum concentration. Generally, the mutant frequencies remained well within the historical range of negative and solvent controls. The control range was only slightly exceeded in the second culture of the first experiment at 25.0 µg/mL without metabolic activation and at 1.6 µg/mL with metabolic activation. These increases were not dose related and no comparable effect occurred in the parallel culture under identical conditions or in the second experiment.
The induction factor exceeded the threshold of three times the factor of corresponding solvent control in the first culture of experiment II without metabolic activation at 25.0 µg/mL. This effect however, was judged to be based upon the rather low solvent control of 5.2 mutant colonies 1E+06 cells. No relevant and reproducible dose dependent increase below this threshold was observed.
In both experiments of this study (with and without S9 mix), the range of the negative and solvent controls was from 4.5 up to 19.5 mutants per 1 million cells ; the range of the groups treated with the test substance was from 1.2 up to 34.3 mutant colonies per 1 million cells.
EMS (0.15 mg/mL) and DMBA (2.5 µg/mL) were used as positive controls and showed a distinct increase in induced mutant colonies. The historical range of positive controls was not quite reached (91.8 versus 97 .8 colonies per 1 million cells) in the second culture of the first experiment without metabolic activation. Still, the threshold of three times the mutation frequency of the corresponding solvent control was clearly exceeded and the historical range was reached in the parallel culture under identical conditions.
In conclusion, it can be stated that under the experimental conditions reported the test substance did not induce gene mutations at the HPRT locus in V79 cells. Therefore, the test substance is considered to be non-mutagenic in this HPRT assay.
Referenceopen allclose all
Analysis of Aberrations (200 cells analyzed); preparation interval 18 hrs without S9 mix: exposure period 4 hrs.
Test Substance |
Dose (µg/mL) |
% Aberrant cells (excl. gaps) |
Chromatid type |
Chromosome type |
||
Break |
Exchange |
Break |
Exchange |
|||
Negative Control |
- |
2.0 |
2 |
0 |
1 |
1 |
Solvent Control |
Deion. water 10 % (v/v) |
0.5 |
0 |
1 |
0 |
0 |
Positive Control |
EMS 400 |
47.5 |
52 |
47 |
9 |
0 |
Protectol HT |
10 |
7.5* |
6 |
8 |
2 |
0 |
20 |
25.5* |
19 |
46 |
5 |
0 |
|
30 |
43.0* |
23 |
83 |
15 |
0 |
Analysis of Aberrations (200 cells analyzed); preparation interval 18 hrs with S9 mix: exposure period 4 hrs.
Test Substance |
Dose (µg/mL) |
% Aberrant cells (excl. gaps) |
Chromatid type |
Chromosome type |
||
Break |
Exchange |
Break |
Exchange |
|||
Negative Control |
- |
2.5 |
3 |
0 |
0 |
0 |
Solvent Control |
Deion. water 10 % (v/v) |
2.0 |
3 |
0 |
1 |
1 |
Positive Control |
CPA 0.7 |
16.5 |
15 |
18 |
2 |
0 |
Protectol HT |
5 |
2.0 |
2 |
0 |
0 |
0 |
10 |
3.0 |
2 |
2 |
2 |
0 |
|
20 |
15.0* |
13 |
18 |
4 |
0 |
* Aberration frequency statiscally significant higher than corresponding control values.
Standard Plate Test:
Mean number of revertants with S-9 mix
Dose/Plate (µg) |
TA 1535 |
TA 100 |
TA 1537 |
TA 98 |
TA 102 |
E.coli WP2 uvrA |
|
Test substance |
25 |
18 |
117 |
13 |
35 |
194 |
27 |
50 |
18 |
111 |
5 |
32 |
130 |
34 |
|
100 |
17/17 |
129/110 |
8/12 |
31/23 |
112 |
35 |
|
200 |
16 |
143 |
11 |
28 |
110 |
30 |
|
400 |
19 |
169 |
11 |
33 |
112 |
37 |
|
500 |
14B |
79 |
4 |
14 |
- |
- |
|
2500 |
0B |
- |
- |
- |
- |
- |
|
Positive control |
2.5 |
142/162 |
1200/1613 |
167/200 |
1182/1216 |
- |
- |
3.0 |
- |
- |
- |
- |
94 |
- |
|
60 |
- |
- |
- |
- |
- |
70 |
|
Vehicle control |
|
16/20 |
145/125 |
10/12 |
34/34 |
229 |
27 |
Positive Control: 2 -Aminoanthracene
17/17 = Mean number of revertants from two experiments (1st and 2nd experiment).
B = Reduced his- and trp- background growth. A decrease in the number of his+ or trp+ revertants was observed from about 400 - 500 µg/plate onward.
Mean number of revertants without S-9 mix
Dose/Plate (µg) |
TA 1535 |
TA 100 |
TA 1537 |
TA 98 |
TA 102 |
E.coli WP2 uvrA |
|
Test substance |
25 |
21 |
129 |
10 |
23 |
150 |
31 |
50 |
18 |
140 |
8 |
27 |
154 |
26 |
|
100 |
19/17 |
132/98 |
6/12 |
28/25 |
126 |
23 |
|
200 |
17 |
119 |
9 |
27 |
102 |
27 |
|
400 |
11 |
117 |
9 |
23 |
104 |
30 |
|
500 |
14B |
75 |
4 |
10 |
- |
- |
|
2500 |
0B |
- |
- |
- |
- |
- |
|
Positive control 1 |
5 |
1183/1620 |
1719/1387 |
- |
- |
- |
- |
Positive control 2 |
100 |
- |
- |
525/538 |
- |
- |
- |
Positive control 3 |
10 |
- |
- |
- |
765/577 |
- |
- |
Positive control 4 |
0.25 |
|
|
|
|
545 |
- |
Positive control 5 |
10 |
|
|
|
|
- |
119 |
Vehicle control |
- |
23/19 |
137/117 |
7/11 |
31/30 |
133 |
21 |
Positive control 1: N-Methyl-N'-nitro-N-nitrosoguanidine
Positive control 2: 9-aminoacridine chloride monohydrate
Positive control 3: 4 -Nitro-o-phenylendiamine
Positive control 4: Mitomycin C
Positive control 5: N-Ethyl-N'-nitro-N-nitrosoguanidine
Preincubation Test:
Mean number of revertants with S-9 mix
Dose/Plate (µg) |
TA 1535 |
TA 100 |
TA 1537 |
TA 98 |
TA 102 |
E.coli WP2 uvrA |
|
Test substance |
25 |
20 |
117 |
12 |
36 |
275 |
32 |
50 |
15 |
119 |
10 |
42 |
205 |
35 |
|
100 |
11 |
116 |
11 |
38 |
233 |
34 |
|
200 |
9 |
116 |
6 |
33 |
234 |
25 |
|
400 |
10 |
132 |
4 |
38 |
189 |
23 |
|
Positive control |
2.5 |
80 |
742 |
83 |
389 |
- |
- |
3.0 |
- |
- |
- |
- |
728 |
- |
|
60 |
- |
- |
- |
- |
- |
222 |
|
Vehicle control |
- |
19 |
130 |
14 |
42 |
291 |
38 |
Positive Control: 2 -Aminoanthracene
Mean number of revertants without S-9 mix
Dose/Plate (µg) |
TA 1535 |
TA 100 |
TA 1537 |
TA 98 |
TA 102 |
E.coli WP2 uvrA |
|
Test substance |
25 |
18 |
114 |
9 |
20 |
186 |
33 |
50 |
21 |
116 |
10 |
16 |
213 |
34 |
|
100 |
16 |
107 |
9 |
19 |
267 |
30 |
|
200 |
20 |
107 |
9 |
25 |
248 |
27 |
|
400 |
17 |
106 |
6 |
37 |
102 |
13 |
|
Positive control 1 |
5 |
705 |
625 |
- |
- |
- |
- |
Positive control 2 |
100 |
- |
- |
623 |
- |
- |
- |
Positive control 3 |
10 |
- |
- |
- |
445 |
- |
- |
Positive control 4 |
0.25 |
- |
- |
- |
- |
736 |
- |
Positive control 5 |
10 |
- |
- |
- |
- |
- |
264 |
Vehicle control |
- |
23 |
111 |
12 |
27 |
214 |
30 |
Positive control 1: N-Methyl-N'-nitro-N-nitrosoguanidine
Positive control 2: 9-aminoacridine chloride monohydrate
Positive control 3: 4 -Nitro-o-phenylendiamine
Positive control 4: Mitomycin C
Positive control 5: N-Ethyl-N'-nitro-N-nitrosoguanidine
Conc. µg/mL |
Mean number of mutant colonies found after plating in TG medium with S9-mix |
||||
Experiment I |
Experiment II |
||||
Culture I |
Culture II |
Culture I |
Culture II |
||
test substance |
0.8 |
- |
- |
- |
- |
1.6 |
5.0 |
8.0 |
- |
- |
|
3.1 |
4.8 |
3.2 |
2.4 |
3.6 |
|
6.3 |
5.0 |
8.0 |
0.4 |
4.0 |
|
12.5 |
7.6 |
4.0 |
3.6 |
3.8 |
|
25.0 |
8.2 |
9.0 |
5.2 |
5.6 |
|
Negative control |
- |
2.2 |
4.6 |
2.2 |
3.6 |
Solvent control with water |
- |
3.8 |
6.0 |
2.8 |
4.6 |
Solvent control with DMSO |
- |
4.4 |
2.6 |
4.2 |
2.2 |
Positive control with DMBA |
2.7 |
176.6 |
201.2 |
150.2 |
131.2 |
DMBA: 7,12-Dimethylbenz(a)anthracene
Conc. µg/mL |
Mean number of mutant colonies found after plating in TG medium without S9-mix |
||||
Experiment I |
Experiment II |
||||
Culture I |
Culture II |
Culture I |
Culture II |
||
test substance |
0.8 |
- |
- |
- |
- |
1.6 |
6.2 |
4.4 |
- |
- |
|
3.1 |
4.2 |
4.6 |
2.4 |
2.6 |
|
6.3 |
5.4 |
3.8 |
3.6 |
3.6 |
|
12.5 |
3.8 |
6.6 |
6.0 |
2.6 |
|
25.0 |
8.0 |
7.8 |
6.0 |
3.2 |
|
Negative control |
- |
5.4 |
5.0 |
1.6 |
3.0 |
Solvent control with water |
- |
4.8 |
3.0 |
1.4 |
3.0 |
Positive control with EMS |
150.0 |
37.0 |
24.4 |
41.2 |
34.6 |
EMS: Ethylmethane sulfonate
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (positive)
Genetic toxicity in vivo
Description of key information
Micronucleus test in mice: negative (BASF
SE, 2002)
UDS test in rats: negative (BASF SE, 2002)
Link to relevant study records
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- micronucleus assay
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Lot/batch No.of test material: 1157 - Species:
- mouse
- Strain:
- NMRI
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: RCC Ltd, Biotechnology & Animal Breeding Division, CH-4414 Fuellinsdorf
- Age at study initiation: 8 - 10 weeks
- Weight at study initiation: mean weight 39.6 ± 3.0 g
- Housing: single
- Cage type: Makrolon Type II, with wire mesh top (Ehret GmbH, Emmendingen)
- Diet (ad libitum): pelleted standard diet
- Water (ad libitum): tap water
- Acclimation period: minimum 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21 ± 4
- Humidity (%): 30 - 70
- Photoperiod (hrs dark / hrs light): 12/12
- Route of administration:
- intraperitoneal
- Vehicle:
- The test material was diluted in deionised water and was administered at a volume of 10 mL/kg b.w. The vehicle control animals were administered deionised water at the same volume.
- Duration of treatment / exposure:
- 24 and 48 hours, respectively.
- Frequency of treatment:
- once
- Dose / conc.:
- 37.5 mg/kg bw (total dose)
- Dose / conc.:
- 75 mg/kg bw (total dose)
- Dose / conc.:
- 150 mg/kg bw (total dose)
- No. of animals per sex per dose:
- 6
- Control animals:
- yes
- Positive control(s):
- Cyclophosphamide (CPA), Dosing: 40 mg/kg bw, Volume administered: 10 mL/kg bw
- Tissues and cell types examined:
- Polychromatic erythrocytes (PCE) in the bone marrow.
- Details of tissue and slide preparation:
- DOSE SELECTION:
The active ingredient content of the test substance was approximately 75%. Therefore, the doses used in this study and reported presently are
expressed in terms of this indicated content. The maximum tolerated dose level is determined to be the dose that causes toxic reactions without having major effects on survival within 48 hours. Three adequate spaced dose levels spaced by a factor of 2 were applied at the central sampling interval 24 h after treatment. For the highest dose level an additional sample was taken at 48 h after treatment.
TREATMENT:
At the beginning of the treatment the animals (including the controls) were weighed and the individual volume to be administered was adjusted to the animals body weight. The animals received the test substance, the vehicle or the positive control substance once ip. Six males were treated per dose group and sampling time. The animals of the highest dose group were examined for acute toxic symptoms at intervals of around 1 h, 2-4h, 6 h and 24 h after administration of the test substance. Sampling of the bone marrow was done 24 and 48 hours after treatment, respectively.
PREPARATION OF THE ANIMALS
The animals were sacrificed by cervical dislocation. The femora were removed, the epiphyses were cut off and the marrow was flushed out with fetal calf serum, using a syringe. The cell suspension was centrifuged at 1500 rpm (390 x g) for 10 minutes and the supernatant was discarded . A small drop of the resuspended cell pellet was spread on a slide. The smear was air-dried and then stained with May-Grünwald/Giemsa. Cover slips were mounted with EUKITT. At least one slide was made from each bone marrow sample.
ANALYSIS OF CELLS:
Evaluation of the slides was performed using NIKON microscopes with 100x oil immersion objectives. At least 2000 polychromatic erythrocytes
(PCE) were analysed per animal for micronuclei. To describe a cytotoxic effect the ratio between polychromatic and normochromatic erythrocytes
was determined in the same sample and expressed in normochromatic erythrocytes per 2000 PCEs . The analysis was performed with coded
slides. - Evaluation criteria:
- A test substance is classified as mutagenic if it induces either a dose-related increase in the number of micronucleated polychromatic erythrocytes, which clearly exceeds the negative control range or a relevant positive response for at least one of the test points.
A test substance producing neither a dose-related increase in the number of micronucleated polychromatic erythrocytes nor a positive response at any of the test points is considered non-mutagenic in this system. - Statistics:
- Statistical significance was evaluated by means of the non-parametric Mann-Whitney test (Krauth J., Annals of Math. Stat., 42: 1949-1956, 1971).
However, the primary point of consideration is the biological relevance of the results. - Key result
- Sex:
- male
- Genotoxicity:
- negative
- Toxicity:
- yes
- Remarks:
- 150 mg/kg bw
- Vehicle controls validity:
- valid
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
- Endpoint:
- in vivo mammalian cell study: DNA damage and/or repair
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 486 (Unscheduled DNA Synthesis (UDS) Test with Mammalian Liver Cells in vivo)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- unscheduled DNA synthesis
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Lot/batch No.of test material: 1157 - Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: RCC Ltd, Biotechnology & Animal Breeding Division, CH-4414 Fuellinsdorf
- Age at study initiation: 6 - 10 weeks
- Weight at study initiation: males: 188.6 g (± 27.7 g); females: 173.4 g (± 18.7 g), mean values
- Fasting period before study: The animals were starved overnight (2 hours treatment) or approximately 6 hours (16 hours treatment) before receiving the test substance, the positive or the vehicle control substance.
- Housing: single
- Cage type: Makrolon Type II, with wire mesh top (Ehret GmbH, Emmendingen)
- Diet (ad libitum): pelleted standard diet
- Water (ad libitum): tap water
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 23 ± 3
- Humidity (%): 30 - 70
- Photoperiod (hrs dark / hrs light): 12/12
- Route of administration:
- oral: gavage
- Vehicle:
- The test material was diluted in deionised water and was administered at a volume of 10 mL/kg b.w. The vehicle control animals were administered
deionised water at the same volume. - Duration of treatment / exposure:
- 2 and 16 hours, respectively
- Frequency of treatment:
- once
- Post exposure period:
- none
- Dose / conc.:
- 375 mg/kg bw (total dose)
- Remarks:
- Male animals
- Dose / conc.:
- 750 mg/kg bw (total dose)
- Remarks:
- Male animals
- Dose / conc.:
- 250 mg/kg bw (total dose)
- Remarks:
- Female animals
- Dose / conc.:
- 500 mg/kg bw (total dose)
- Remarks:
- Female animals
- No. of animals per sex per dose:
- 4
- Control animals:
- no
- Positive control(s):
- - 2 hours preparation interval: DMH; N,N'-Dimethylhydrazinedihydrochloride (sym.), Purity: >99 %, Dosing: 40 mg/kg bw, Vol. admin.: 10 mL/kg bw
- 16 hours preparation interval: 2-AAF; 2-Acetylaminofluorene, Purity: >99%, Dosing: 100 mg/kg bw, Vol. admin.: 10 mL/kg bw - Details of tissue and slide preparation:
- DOSE SELECTION:
The active ingredient content of the test substance was approximately 75%. Therefore, the doses used in this study and reported presently are
expressed in terms of this indicated content. The highest doses used in this test system (750 and 500 mg/kg bw for males and females, respectively) were estimated by the pre-experiments to be suitable. The low doses were half of the high doses.
TREATMENT:
4 male and 4 female rats were assigned to each test group. The animals were starved overnight (2 hours treatment) or approximately 6 hours (16 hours treatment) before receiving the test substance, the positive or the vehicle control substance. Before the beginning of the treatment the animals were weighed and the individual volume to be administered was adjusted to the body weight of the animals. The animals received the test substance once.
ISOLATION OF THE PRIMARY HEPATOCYTES:
After anaesthetizing the rats with Na-thiopental, the liver was perfused through the vena portae with Hanks' balanced salt solution supplemented with collagenase (0.05 %(w/v), adjusted to pH 7.4 and maintained at 37 °C. The isolated hepatocytes were washed twice with HBSS. The crude cell suspension was filtered through a stainless steel mesh (94 µm) to yield a single cell suspension. The quality of the performed perfusion was determined by the trypan blue dye exclusion method for cell viability. In addition, the number of the cells was determined.
CULTURE CONDITIONS:
The washed hepatocytes were centrifuged and transferred into Williams medium E supplemented with:
Hepes 2.38 mg/mL, L-Glutamine 0.29 mg/mL, Penicillin 100 units/mL, Insulin 0.50 µg/mL, Streptomycin 0.10 mg/mL and Fetal calf serum 100 µL/mL. This complete medium was adjusted to pH 7.6.
At least three cultures were established from each animal. Aliquots of 2.5 mL with freshly isolated hepatocytes in complete culture medium (2.0xE+05 viable cells/mL) were added to 35 mm six-well dishes containing one 25 mm round plastic coverslip per well coated with gelatine.
After an attachment period of approximately 1.5 h in a 95 % air/ 5% CO2 humidified incubator at 37 °C the culture medium was discarded. Then, the cell layer was rinsed once with PBS to remove non-adherent cells. Subsequently, 3HTdR in 2.0 mL culture medium (WME, 1%(v/v) FCS) was added to the cultures. After a labelling time of 4 h the cells were washed twice with WME supplemented with 1%(v/v) FCS and 0.25 mM unlabelled thymidine.
Cultures were incubated overnight using the same medium. To prepare for autoradiography the medium was replaced by a hypotonic solution of
1%(w/v) sodium citrate for 10 minutes to swell the nuclei for better grain detection. The cells on the coverslips were then fixed by three changes of methanol:acetic acid (3+1 v/v) for 20 minutes each, rinsed with 96 %(v/v) ethanol, and air-dried.
AUTORADIOGRAPHY:
The cover slips were mounted the side carrying the cells up on glass slides and coated with KODAK NTB2 photographic emulsion in the dark.
The coated slides were stored in light-proof boxes in the presence of a drying agent for 14 days at 4 °C. The photographic emulsion was then
developed with KODAK Dektol Developer at room temperature, fixed in TETENAL and stained with hematoxylin/eosin.
EVALUATION OF UDS:
Evaluation was performed microscopically on coded slides using NIKON microscopes with oil immersion objectives. The cells for scoring were
randomly selected according to a fixed scheme. The number of silver grains in the nuclear area was counted automatically using the ARTEK 880 or 982 counter. In addition, the number of grains of the most heavily lableled nuclear-sized cytoplasm area adjacent to the nucleus was counted.
At least two slides per animal and 50 cells per slide were evaluated. Heavily radiolabeled cells undergoing replicative DNA synthesis were excluded from counting. - Evaluation criteria:
- Nuclear and net grain counts are estimated together. Increased net grains should be based on enhanced nuclear grain counts rather than on decreased cytoplasmic grain counts.
A test substance is classified as positive if the mean number of net grains is higher than five per nucleus at one of the test points.
A group average between 0 and 5 net grains is considered as a marginal response. A dose-related increase in nuclear and net grains and/or a substantial shift of the percentage distribution of the nuclear grain counts to higher values provide additional information to confirm a positive response with less than 5 net grains.
A test substance producing net grains not greater than 0 at anyone of the test points is considered non-effective in this system. - Statistics:
- Statistical significance was evaluated by means of the non-parametric Mann-Whitney test (Krauth J., Annals of Math. Stat., 42: 1949-1956, 1971).
- Key result
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- not applicable
- Positive controls validity:
- valid
Referenceopen allclose all
Summary of the Micronucleus Test Results:
Test group |
Period |
Dose (mg/kg bw) |
PCEs with micronuclei |
range |
PCE/ NCE |
deionised water |
24 h |
0 |
0.60 |
0 – 4 |
2000/ 1937 |
CPA |
24 h |
40 |
16.90 |
23 – 55 |
2000/ 1760 |
Protectol HT
|
24 h |
37.5 |
0.20 |
0 – 1 |
2000/ 2053 |
24 h |
75.0 |
0.50 |
0 – 3 |
2000/ 1792 |
|
24 h |
150.0 |
1.50 |
1 – 8 |
2000/ 2368 |
|
deionised water |
48 h |
0 |
0.40 |
0 – 4 |
2000/ 1880 |
Protectol HT |
48 h
|
150.0 |
0.80 |
0 – 3 |
2000/ 2535 |
CPA: Cyclophosphamide
Mean Nucleus, Cytoplasmic Area and Net Grains (mean values of 3 animals).
Treatment |
Period |
Dose (mg/kg bw) |
Grains per nucleus |
Grains per cytoplasmatic area |
Net grains per nucleus |
||||
|
male |
female |
male |
female |
male |
female |
male |
female |
|
deionised water |
2 h |
- |
- |
13.74 |
6.24 |
21.14 |
11.57 |
-7.40 |
-5.33 |
DMH |
2 h |
40 |
40 |
30.27 |
28.29 |
17.50 |
8.39 |
12.77 |
19.90 |
Protectol HT |
2 h |
375 |
250 |
13.00 |
6.21 |
19.60 |
11.19 |
-6.60 |
-4.98 |
2 h |
750 |
500 |
13.91 |
7.18 |
19.76 |
11.65 |
-5.85 |
-4.47 |
|
deionised water |
16 h |
- |
- |
9.75 |
7.83 |
15.96 |
14.05 |
-6.22 |
-6.21 |
2-AAF |
16 h |
100 |
100 |
45.28 |
23.53 |
19.98 |
15.12 |
25.30 |
8.41 |
Protectol HT |
16 h |
375 |
250 |
12.38 |
8.61 |
22.00 |
15.23 |
-9.62 |
-6.62 |
16 h |
750 |
500 |
12.97 |
7.50 |
18.77 |
18.19 |
-5.80 |
-10.69 |
DMH: N,N'-Dimethylhydrazinedihydrochloride
2-AAF: 2-Acetylaminofluorene
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
In vitro:
The mutagenic potential of the test substance was investigated in several in vitro studies in compliance with GLP: A Salmonella/microsome assay (Ames test; BASF SE, 1997), a Salmonella assay (Ames test; BASF SE, 1981), a cytogenetic assay for chromosome aberrations in Chinese hamster V79 cells (BASF SE, 2002), and a gene mutation at the HPRT locus in Chinese hamster V79 cells (HPRT test; BASF SE, 2002). All studies were performed both with and without a metabolic activation system to investigate the potential effect of metabolites of the test substance on the test systems. The Ames test and HPRT test gave no indication for a mutagenic potential of the test substance with and without metabolic activation. In contrast, the test substance showed a positive response in the chromosomal aberration test with and without metabolic activation.
These results are supported by further GLP guideline studies: Ames test negative (L.A.C.S.A., 2015), HPRT test negative (L.A.C.S.A., 2015) and in vitro micronucleus test in human peripheral blood positive (L.A.C.S.A., 2015).
In addition, the substance was tested to be not mutagenic in another Ames test (BASF, 1981), whereas ambiguous results were reported in an Ames test performed in course of the US National Toxicology Program (Mortelsmann, 1986). The substance was not genotoxic in an in vitro UDS assay (Troy, 1993).
In vivo:
The evidence for a clastogenic potential of the test substance from an in vitro chromosomal aberration test could not be confirmed in an in vivo micronucleus test with intraperitoneal application in mice according to OECD TG 474 in compliance with GLP (BASF SE, 2002). There was not any substantial enhancement in the frequency of the detected micronuclei at any preparation interval after administration of the test substance and with any dose level used (37.5, 75.0, 150.0 mg/kg bw).
The test substance was negative in an UDS test with liver cells in vivo in rats according to OECD TG 486 in compliance with GLP (BASF SE, 2002). In this study with oral administration by gavage, the substance was tested at doses of 375 and 750 mg/kg bw in males, and 250 and 500 mg/kg bw in females. The viability of the hepatocytes was not substantially affected by the in-vivo substance treatment. The test substance did not reveal at any dose level UDS induction in the hepatocytes of the treated animals as compared to the concurrent vehicle (deionised water) controls.
Justification for classification or non-classification
The available experimental test data are reliable and suitable for classification purposes under Regulation 1272/2008. The positive result in the in vitro chromosome aberration assay was not confirmed by two in vivo tests. Thus, the test substance does not need to be classified and labelled according to Regulation (EC) No 1272/2008, as amended for the ninth time in Regulation (EU) No 2016/1179.
.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)